AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
HYOSCINE BUTYLBROMIDE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CP-HYOSCINE SOLUTION; INJECTION | 2026/16.4/7321 | COSPHARM INVESTMENTS PVT LTD | active | 1 Mar 2031 |
| HYOSPASMOL INJECTABLE; INJECTION | 99/16.4/3577 | PHARMACARE LIMITED | active | 8 Apr 2030 |
| HYOSPASMOL TABLET, COATED; ORAL | 91/16.4/2563 | PHARMACARE LIMITED | active | 31 Dec 2027 |
| RIDZ-HYOSCINE TABLET, COATED; ORAL | 2024/16.4/6675 | RIDZ PHARMA | active | 31 Dec 2027 |
| HYOSCINE BUTYLBROMIDE TABLET, COATED; ORAL | 96/16.4/3022 | REMEDICA LTD | active | 31 Dec 2027 |
HYOSCINE BUTYLBROMIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing HYOSCINE BUTYLBROMIDE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track HYOSCINE BUTYLBROMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.